-+ 0.00%
-+ 0.00%
-+ 0.00%

Jefferies Initiates Coverage On Damora Therapeutics with Buy Rating, Announces Price Target of $50

Benzinga·07/27/2026 10:49:19
Listen to the news
Jefferies analyst Akash Tewari initiates coverage on Damora Therapeutics (NASDAQ:DMRA) with a Buy rating and announces Price Target of $50.